Clinical Trial Update: Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating image-guided, tumor-focused radiotherapy for intermediate- and high-risk prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, San Diego | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING